{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:38:33Z","timestamp":1760985513585},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Education and Science of Spain and Miguel Hernandez University","award":["FPU AP2010-2372"],"award-info":[{"award-number":["FPU AP2010-2372"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.euroneuro.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T01:31:05Z","timestamp":1479346265000},"page":"1868-1876","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Population pharmacokinetic model of lithium and drug compliance assessment"],"prefix":"10.1016","volume":"26","author":[{"given":"Isabel","family":"P\u00e9rez-Castell\u00f3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor","family":"Mangas-Sanjuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Gonz\u00e1lez-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Gonzalez-Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marival","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Marco-Garbayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1aki F.","family":"Troc\u00f3niz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2016.11.005_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00561406","article-title":"Plasma and intracellular kinetics of lithium after oral administration of various lithium salts","volume":"12","author":"Altamura","year":"1977","journal-title":"Eur. J Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib2","unstructured":"Bauer, R., 2011. NONMEM users guide: introduction to NONMEM 7.2.0.. ICON Development Solutions, Ellicott City."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib4","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1176\/appi.ajp.162.10.1805","article-title":"Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials","volume":"162","author":"Cipriani","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.11.005_bib5","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1586\/14737175.2014.947965","article-title":"Lithium for bipolar disorder: a review of the recent literature","volume":"14","author":"Curran","year":"2014","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2125.2007.02975.x","article-title":"Overview of model-building strategies in population PK\/PD analyses: 2002\u20132004 literature survey","volume":"64","author":"Dartois","year":"2007","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5414\/CPP46617","article-title":"Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach","volume":"46","author":"ElDesoky","year":"2008","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10928-015-9439-8","article-title":"Bayesian population modeling of drug dosing adherence","volume":"42","author":"Fellows","year":"2015","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/JCP.0b013e3181e66a62","article-title":"First-dose pharmacokinetics of lithium carbonate in children and adolescents","volume":"30","author":"Findling","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.161.2.217","article-title":"Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials","volume":"161","author":"Geddes","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.11.005_bib11","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF02353671","article-title":"Do we need full compliance data for population pharmacokinetic analysis?","volume":"24","author":"Girard","year":"1996","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"Suppl 4","key":"10.1016\/j.euroneuro.2016.11.005_bib12","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0924-977X(99)00026-7","article-title":"Prophylaxis of bipolar disorder: how and who should we treat in the long term?","volume":"9","author":"Goodwin","year":"1999","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11596990-000000000-00000","article-title":"Therapeutic drug monitoring of imatinib: bayesian and alternative methods to predict trough levels","volume":"51","author":"Gotta","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/00023210-200923040-00005","article-title":"Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.euroneuro.2016.11.005_bib15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.11.005_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2125.1988.tb03316.x","article-title":"Steady-state pharmacokinetics of lithium carbonate in healthy subjects","volume":"25","author":"Hunter","year":"1988","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib17","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/FTD.0b013e31823615e1","article-title":"A population pharmacokinetic\/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma","volume":"33","author":"Johansson","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib18","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1023\/A:1011970125687","article-title":"Automated covariate model building within NONMEM","volume":"15","author":"Jonsson","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose--an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM","volume":"58","author":"Jonsson","year":"1999","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF01113502","article-title":"The importance of modeling interoccasion variability in population pharmacokinetic analyses","volume":"21","author":"Karlsson","year":"1993","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00007691-199702000-00005","article-title":"Population pharmacokinetics of felbamate in children","volume":"19","author":"Kelley","year":"1997","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib22","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.2147\/DDDT.S84718","article-title":"Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics","volume":"9","author":"Kim","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10928-006-9032-2","article-title":"Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria","volume":"34","author":"Kshirsagar","year":"2007","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10928-006-9022-4","article-title":"A non-linear mixed effect dynamic model incorporating prior exposure and adherence to treatment to describe long-term therapy outcome in HIV-patients","volume":"33","author":"Labbe","year":"2006","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/clpt.1993.143","article-title":"A pharmacokinetic perspective on medicament noncompliance","volume":"54","author":"Levy","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmpb.2005.04.005","article-title":"PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM","volume":"79","author":"Lindbom","year":"2005","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1023\/A:1011582713692","article-title":"Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance","volume":"28","author":"Lu","year":"2001","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2125.2000.00174.x","article-title":"Therapeutic drug monitoring of psychotropic medications","volume":"49","author":"Mitchell","year":"2000","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib29","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/S0149-2918(02)80081-9","article-title":"Open-label study of the effect of combination quetiapine\/lithium therapy on lithium pharmacokinetics and tolerability","volume":"24","author":"Potkin","year":"2002","journal-title":"Clin. Ther."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2165\/00002512-200016030-00002","article-title":"Differential pharmacokinetics of lithium in elderly patients","volume":"16","author":"Sproule","year":"2000","journal-title":"Drugs Aging"},{"key":"10.1016\/j.euroneuro.2016.11.005_bib31","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40345-016-0047-3","article-title":"Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications","volume":"4","author":"Szmulewicz","year":"2016","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/01.ftd.0000158083.45954.97","article-title":"Predicting the usefulness of therapeutic drug monitoring of mycophenolic acid: a computer simulation","volume":"27","author":"van Hest","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bdi.12025","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013","volume":"15","author":"Yatham","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00007691-199304000-00002","article-title":"Lithium population pharmacokinetics from routine clinical data: role of patient characteristics for estimating dosing regimens","volume":"15","author":"Yukawa","year":"1993","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.euroneuro.2016.11.005_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/archdischild-2012-302765","article-title":"Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring","volume":"98","author":"Zhao","year":"2013","journal-title":"Arch. Dis. Child"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16319800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16319800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T16:05:00Z","timestamp":1656864300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X16319800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0924977X16319800"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.11.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Population pharmacokinetic model of lithium and drug compliance assessment","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}